mark levis, md, phd, regarding the impact of next-generation sequencing in aml
Published 6 years ago • 95 plays • Length 0:56
Download video MP4
Download video MP3
Similar videos
-
1:19
dr. kambhampati on the impact of next-generation sequencing in aml
-
1:50
mark levis, md, on why the flt3 target is important in aml
-
1:21
mark levis, md, on the mechanism of action for cpx-351 (vyxeos) and why is it promising in aml
-
5:17
impact of targeted therapies on treatment of mds and aml
-
1:20
mark levis, md, phd, comments on measurable residual disease in relapsed/refractory aml
-
1:18
dr. levis discusses the ideal use of quizartinib in flt3-itd aml
-
3:33
what is next generation sequencing ngs? #aml
-
0:59
mark levis, md, discusses significance of the quantum-r study
-
1:29:05
concepts of next generation sequencing
-
41:15
webinar next generation sequencing (ngs)
-
2:27
what is ngs (next generation sequencing)? #mds
-
0:35
management & outcome of patients with cbf aml and flt3-itd
-
1:34
eunice wang, md, on next-generation sequencing and treatment selection in aml
-
0:18
mark levis, md, discusses the role of checkpoint inhibitors in treating hematological malignancies
-
2:03
mark levis, md, phd, on factors influencing 1st line therapy in aml patients with flt3 mutations
-
1:24
mark levis, md, phd, discusses what we've learned about gilteritinib in flt3 mutated aml patients
-
1:03
mark levis, md, phd, discusses exciting data from the 2018 asco annual meeting
-
10:20
next-generation sequencing for oncologists
-
1:37
dr. levis on the background and future of quizartinib for aml
-
2:48
may the force be with you: the power of next-generation sequencing
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
3:11
uses of ngs in aml
Clip.africa.com - Privacy-policy